Ketamine and esketamine during breastfeeding: a systematic review of human pharmacokinetic, infant and lactation outcomes

Ketamine is used in anaesthesia and analgesia, and esketamine nasal spray is licensed as a rapidly acting treatment for treatment-resistant depression; both uses overlap with the postpartum period. We synthesised human evidence on transfer into milk, infant exposure, infant outcomes and breastfeeding outcomes.